U.S. markets open in 1 hour
  • S&P Futures

    4,171.00
    +8.50 (+0.20%)
     
  • Dow Futures

    33,986.00
    +63.00 (+0.19%)
     
  • Nasdaq Futures

    14,050.75
    +36.75 (+0.26%)
     
  • Russell 2000 Futures

    2,261.70
    +6.00 (+0.27%)
     
  • Crude Oil

    63.53
    +0.07 (+0.11%)
     
  • Gold

    1,781.30
    +14.50 (+0.82%)
     
  • Silver

    26.28
    +0.32 (+1.24%)
     
  • EUR/USD

    1.1986
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    1.5300
    0.0000 (0.00%)
     
  • Vix

    16.40
    -0.59 (-3.47%)
     
  • GBP/USD

    1.3803
    +0.0018 (+0.13%)
     
  • USD/JPY

    108.8320
    +0.1160 (+0.11%)
     
  • BTC-USD

    60,983.36
    -1,473.19 (-2.36%)
     
  • CMC Crypto 200

    1,357.45
    -23.50 (-1.70%)
     
  • FTSE 100

    7,020.90
    +37.40 (+0.54%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PEN, CLOV and EBIX

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / March 3, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Penumbra, Inc. (NYSE:PEN)
Class Period: August 3, 2020 - December 15, 2020
Lead Plaintiff Deadline: March 16, 2021

During the class period, Penumbra, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) that the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; (2) that Penumbra did not adequately address the risk of the Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; (3) that the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and (4) as a result, Penumbra's public statements as set forth above were materially false and misleading at all relevant times.

Learn about your recoverable losses in PEN: http://www.kleinstocklaw.com/pslra-1/penumbra-inc-loss-submission-form?id=13269&from=1

Clover Health Investments, Corp. (NASDAQ: CLOV)
Class Period: October 6, 2020 - February 3, 2021
Lead Plaintiff Deadline: April 6, 2021

The CLOV lawsuit alleges that Clover Health Investments, Corp. made materially false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover's sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover's
subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover's software was in fact rudimentary; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in CLOV: http://www.kleinstocklaw.com/pslra-1/clover-health-investments-corp-loss-submission-form?id=13269&from=1

Ebix, Inc. (NASDAQ:EBIX)
Class Period: November 9, 2020 - February 19, 2021
Lead Plaintiff Deadline: April 23, 2021

The complaint alleges Ebix, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) that there was insufficient audit evidence to determine the business purpose of certain significant unusual transactions in Ebix's gift card business in India during the fourth quarter of 2020; (2) that there was a material weakness in Company's internal controls over the gift or prepaid revenue transaction cycle; and (3) that the Company's independent auditor was reasonably likely to resign over disagreements with Ebix regarding $30 million that had been transferred into a commingled trust account of Ebix's outside legal counsel; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in EBIX: http://www.kleinstocklaw.com/pslra-1/ebix-inc-loss-submission-form?id=13269&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/633296/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-PEN-CLOV-and-EBIX